Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
06/2009
06/23/2009US7550456 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder
06/23/2009US7549978 Needle assembly
06/23/2009CA2449874C New indole derivatives with 5-ht6 receptor affinity
06/23/2009CA2420694C Guanidinobenzamides as mc4-r agonists
06/23/2009CA2405937C Methylation of indole compounds using dimethyl carbonate
06/23/2009CA2326833C Indolyl-3-glyoxylic acid derivatives with antitumoral activity
06/23/2009CA2300148C Nicotine antagonists for nicotine-responsive neuropsychiatric disorders
06/18/2009WO2009074733A2 Addition salts of angiotensine-converting enzyme inhibitors with no donor acids, method for preparing same and pharmaceutical compositions containing same
06/18/2009WO2009074496A1 Rhodium-phosphorus complexes and their use in ring opening reactions
06/18/2009WO2009046841A3 Piperidine and piperazine derivatives for treating tumours
06/18/2009WO2009044019A3 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
06/18/2009WO2009018280A3 Substituted indoles
06/18/2009WO2009016081A3 Benzoind0l-2-one derivatives for use in therapy
06/18/2009WO2008156816A3 Renin inhibitors
06/18/2009WO2008099000A3 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
06/18/2009WO2007027532A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment
06/18/2009US20090156824 Hydroamination of Alkenes
06/18/2009US20090156640 Nociceptin analogs
06/18/2009US20090156607 2-oxo-1-pyrrolidine derivatives
06/18/2009US20090156556 Aminopropanol derivatives
06/18/2009US20090155903 Pharmaceutical composition and method
06/18/2009US20090153021 Large-bandgap host materials for phosphorescent emitters
06/17/2009EP2070904A1 Rhodium-phosphorus complexes and their use in ring opening reactions
06/17/2009EP2070899A1 Deprotection of N-BOC compounds
06/17/2009EP2069291A1 Hdac inhibitors
06/17/2009EP2069289A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS
06/17/2009EP1836166B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/17/2009EP1628958B1 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
06/17/2009EP1611088B1 Hydroxamates as therapeutic agents
06/17/2009CN101460459A Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use
06/17/2009CN101460458A Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
06/17/2009CN101456840A Substituted tetrahydro carbazole derivates with optically activity and synthetic method thereof
06/17/2009CN101456839A 3,6-dichloro-9-(2-(4-methylpiperazine-1-yl)ethyl)-9H-carbazole and preparation method thereof
06/17/2009CN101456838A 2-(2-nitro ethyl)-4,7-dihydro indole compounds, synthetic method and use
06/17/2009CN100500654C Tetrahydrocarbazol derivatives as ligands for g-protein-coupled receptors (gpcr)
06/16/2009US7547800 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
06/16/2009US7547731 Antiinflammatory agents; antiallergens; respiratory system disorders
06/16/2009US7547716 Sulfonamide derivatives
06/16/2009US7547703 Indoline derivatives substituted in the 6-position, their preparation and their use as medicaments
06/16/2009CA2451474C Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
06/16/2009CA2264750C Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
06/11/2009WO2009073380A1 Dehydrohalogenation process for the preparation of intermediates useful in providing 6,6-dimethyl-3-azabicyclo-[3.1.0]-hexane compounds
06/11/2009WO2009072587A1 Carbazole derivative, and light-emitting element, light-emitting device, and electronic device using carbazole derivative
06/11/2009WO2009072581A1 Lactam compound or salt thereof, and ppar activator
06/11/2009WO2009071957A2 Novel peptides and amino acid derivatives, pharmaceutical compositions containing same and the use of these compounds
06/11/2009WO2009071524A2 Indolinone derivatives and process for their manufacture
06/11/2009WO2009071523A1 Process for the manufacture of an indolinone derivative
06/11/2009WO2009054653A3 Isoindolones with high binding affinity to beta-amyloid aggregates and fibrils, and its use and preparation method
06/11/2009US20090149662 Processes for preparing zafirlukast
06/11/2009US20090149660 Optical recording material and optical recording media
06/11/2009US20090149505 Metabotropic Glutamate Receptor-Potentiating Isoindolones
06/11/2009US20090149460 New Compounds
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
06/11/2009US20090149415 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex
06/11/2009US20090148407 Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication
06/11/2009US20090146558 Stilbene Derivatives, Light-Emitting Element and Light-Emitting Device
06/11/2009CA2707008A1 Dehydrohalogenation process for the preparation of intermediates useful in providing 6,6-dimethyl-3-azabicyclo-[3.1.0]-hexane compounds
06/11/2009CA2706423A1 Process for the manufacture of an indolinone derivative
06/11/2009CA2705490A1 Indolinone derivatives and process for their manufacture
06/10/2009EP2066629A1 Anthracene derivative, and light emitting element, light emitting device, and electronic device using the anthracene derivative
06/10/2009EP2066628A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists
06/10/2009EP2066318A2 Oxindole derivatives as anticancer agents
06/10/2009EP1532105B1 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof
06/10/2009EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure
06/10/2009CN101454284A Bi-aryl or aryl-heteroaryl substituted indoles
06/10/2009CN101454283A Nitrated heterocyclic compounds as endothelin receptor antagonist
06/10/2009CN101450907A Processes for the preparation of glutamic acid compounds and intermediates thereof and novel intermediates used in the processes
06/10/2009CN100497308C Large scale preparation method for 3-[2-(dimethylamido)ethyl]-N-methyl-1-hydro-indoly-5-methanesulfonamide
06/10/2009CN100497302C Diarylurea derivatives and their use as chloride channel blockers
06/09/2009US7544835 Carboxylic acid derivative and salt thereof
06/09/2009US7544815 Process for making hydroisoindoline tachykinin receptor antagonists
06/09/2009US7544711 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents
06/09/2009US7544708 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide
06/09/2009US7544698 Indoles and benzoimidazoles as modulators of the histamine H4 receptor
06/09/2009US7544685 2,3-dihydroindole compounds
06/09/2009US7544312 Charge transport compositions and electronic devices made with such compositions
06/09/2009US7544215 Neutral and cationic naphthalene and colorants for keratin fibers containing these compounds
06/09/2009CA2583764C Thrombopoietin activity modulating compounds and methods
06/09/2009CA2251331C Calcilytic compounds
06/04/2009WO2009069610A1 Fused indane compound
06/04/2009WO2009069602A1 Benzanthracene compound and organic electroluminescent device using the same
06/04/2009WO2009068463A2 Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates
06/04/2009WO2009051417A3 Phenanthrene lactam derivatives having anticancer activity and method for the preparation thereof
06/04/2009WO2009040314A3 Novel heteroaryl-substituted acetone derivatives, suitable for inhibiting phospholipase a2
06/04/2009US20090143592 Glucagon Antagonists/Inverse Agonists
06/04/2009US20090143581 Synthesis of avrainvillamide, strephacidin b, and analogues thereof
06/04/2009US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof
06/04/2009US20090143457 Polycyclic compounds for use in treating ocular neurodegenerative diseases
06/04/2009US20090143449 Bi-Aryl or Aryl-Heteroaryl Substituted Indoles
06/04/2009US20090143406 New Phenylpiperazine
06/04/2009US20090143389 Heterocyclic inhibitors of mek and methods of use thereof
06/04/2009US20090143382 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
06/04/2009US20090143376 Fused Heterocyclic Compounds and Their Use as Sirtuin Modulators
06/04/2009US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors
06/04/2009US20090142832 Indoles, Derivatives, and Analogs Thereof and Uses Therefor
06/04/2009CA2706171A1 Fused indane compound
06/04/2009CA2705950A1 Preparation of dihydropyrrol derivatives as intermediates
06/03/2009EP2065369A1 Urea compound or salt thereof
06/03/2009EP2064181A1 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
06/03/2009EP2064180A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections